Oral naltrexone maintenance treatment for opioid dependence
about
Psychosocial treatment for opiate abuse and dependenceInterventions for drug-using offenders in the courts, secure establishments and the communityPsychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependenceOpioid antagonists with minimal sedation for opioid withdrawalPharmacological therapies for maintenance treatments of opium dependencyPsychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependenceMaintenance treatments for opiate dependent adolescentMaintenance agonist treatments for opiate dependent pregnant womenMaintenance treatments for opiate dependent pregnant womenInterventions for drug-using offenders in the courts, secure establishments and the communityPsychosocial treatment for opiate abuse and dependenceOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaCost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in MalaysiaThe effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trialNovel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.Opioid dependence treatment: options in pharmacotherapy.The association between naltrexone treatment and symptoms of depression in opioid-dependent patientsOpioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Improving public health through access to and utilization of medication assisted treatmentHepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practiceMedication-assisted treatment research with criminal justice populations: challenges of implementation.Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid DependenceMaintenance of reinforcement to address the chronic nature of drug addiction.Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineAvailability of addiction medications in private health plans.Naltrexone extended-release injection: an option for the management of opioid abuse.Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.Medications for substance use disorders.Long-term outcome of in-patients with substance use disorders: A study from North India.Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.Advances in the delivery of buprenorphine for opioid dependence.Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.
P2860
Q24197551-E63A0A2E-D76F-46B8-B8A4-06AA4404BDF7Q24200641-319D0767-2374-4C4D-9A63-E698448BBB59Q24235930-1DBB8B0F-385A-490F-AD20-4E2A7331B4F1Q24240041-EA23F2BE-3FB5-4BF4-9559-C717B6A6292BQ24240562-B5D7686A-FD7D-45FC-BB7A-B4C57339B846Q24241043-815563BB-1E8E-4F3E-9698-36F19EA53CDDQ24241116-84F67FFE-3DE2-42D3-AFEC-986A00F4FC91Q24242986-983C4AA4-3FDC-4872-BE7D-E7271292EB6CQ24243740-5EDC2C6B-70D9-490A-BE2B-6C06B0DF389FQ24245560-24559946-BE0C-4C81-BA2A-2D2EB1DF75D0Q24245630-A5019B2C-1346-45CE-8107-0CB59CDBC3FAQ26778626-C7DEC357-7635-4828-A536-D0D73671C6CFQ28485456-650023BE-AC36-4492-83B0-64E2B1F14574Q30490602-64EBACE5-D335-4320-AACC-70D4CEE88D8BQ33700165-6DE90CB4-7B67-44DD-B8B0-B5D336CF8B94Q33735205-D3A84749-C0E2-4F2F-9FBA-4E11D9AFE19EQ33868638-97C1837A-2393-4FD5-99C2-71531694B423Q35034221-E1E733BA-2E0A-403B-A7EA-2602D945E31FQ35090939-8B7500DA-9015-41A3-830C-15A39AA55799Q35534893-21433A65-F51C-4F77-B1D1-25887B0F0B54Q35566908-919244F9-731D-4FFF-B885-F65471A72355Q35571120-21601E6E-6317-4853-8404-70A2CD46FFBFQ35627363-05075F83-0D34-4C71-B7AE-ADACA4136BD1Q35751878-F953F295-57BA-45BD-AA13-D8195EB9A2E0Q36218625-84D5302C-1A80-48F4-A9E1-59295BAFD499Q36394777-1B6E52F4-C066-4896-904C-BC2943E20AAFQ36594523-AAB5C7D4-A605-4AEB-9CD0-1EB5DCFA276AQ37355293-6D01D5F8-A341-4543-B6A8-0565308C8C33Q37873579-089DD55A-C03A-45E6-8A80-974A6611CB2DQ38111473-5890F217-86C1-4560-9EBC-2781EEB4B2A8Q38448398-6D655868-788E-4F87-A9EA-F46B59FC83F1Q43117967-E183CB5C-8C4E-45F0-9E76-18C47E35DB00Q45946172-943F74C5-B2FC-48E6-A304-4595EDAECD5CQ47909566-D156640E-D7CC-4B19-8628-ED3BD75BFCC1
P2860
Oral naltrexone maintenance treatment for opioid dependence
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Oral naltrexone maintenance treatment for opioid dependence
@ast
Oral naltrexone maintenance treatment for opioid dependence
@en
Oral naltrexone maintenance treatment for opioid dependence
@en-gb
Oral naltrexone maintenance treatment for opioid dependence
@nl
type
label
Oral naltrexone maintenance treatment for opioid dependence
@ast
Oral naltrexone maintenance treatment for opioid dependence
@en
Oral naltrexone maintenance treatment for opioid dependence
@en-gb
Oral naltrexone maintenance treatment for opioid dependence
@nl
prefLabel
Oral naltrexone maintenance treatment for opioid dependence
@ast
Oral naltrexone maintenance treatment for opioid dependence
@en
Oral naltrexone maintenance treatment for opioid dependence
@en-gb
Oral naltrexone maintenance treatment for opioid dependence
@nl
P2860
P50
P1476
Oral naltrexone maintenance treatment for opioid dependence
@en
P2093
Annette Verster
P2860
P356
10.1002/14651858.CD001333.PUB2
P577
2006-01-25T00:00:00Z